You may have seen our recent announcement that MediSieve has received over £1.75 million in funding.

The cash influx has come from a mix of both old and new investors – reflecting the growing confidence in the potential of the device. The medical device company is best known for their magnetic blood filtration technology, a revolutionary new approach to targeting blood-borne diseases by magnetically filtering specific disease-causing components from the bloodstream. The device is being tested for the treatment of Malaria, Sepsis and Leukaemia.

As part of the latest funding round the private capital network 24Haymarket invested £632k with Marek Gumienny (Director of 24Haymarket) joining the board of MediSieve as a Non-Executive Director. This investment will contribute greatly to the further research and development of the company, providing a strong potential partner and source of capital to the company for the future.

The below websites have kindly featured our annoucement. Please do browse the following links to read more.

Royal Academy of Engineering

UK Tech News

BDaily News

Building Better Healthcare

To read the full story, check out out news page here.

You may have seen our recent announcement that MediSieve has received over £1.75 million in funding.

See where our news has been covered. 

Sort by: Newest First Oldest First Most Popular Most unliked